289 top medical experts on Neurofibrosarcoma across 27 countries and 27 U.S. states, including 174 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Neurofibrosarcoma: A malignant tumor that arises from small cutaneous nerves, is locally aggressive, and has a potential for metastasis. Characteristic histopathologic features include proliferating atypical spindle cells with slender wavy and pointed nuclei, hypocellular areas, and areas featuring organized whorls of fibroblastic proliferation. The most common primary sites are the extremities, retroperitoneum, and trunk. These tumors tend to present in childhood, often in association with neurofibromatosis 1. (From DeVita et al., Cancer: Principles & Practice of Oncology, 5th ed, p1662; Mayo Clin Proc 1990 Feb;65(2):164-72)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Fibrosarcoma (1,240), Neurofibroma (2,018).
  4. Clinical Trials ClinicalTrials.gov : at least 52 including 10 Active, 18 Completed, 17 Recruiting
  5. Synonyms: Malignant Peripheral Nerve Sheath Tumors,  Neurilemmosarcoma,  Neurogenic Sarcoma


  

        

                    


    Computing Expert Listing ...

);